共 50 条
- [3] Cost effectiveness of adalimumab (HUMIRA™, Abbott) in the treatment of patients with moderate to severe rheumatoid arthritis (RA) ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S215 - S215
- [5] The cost-effectiveness of adalimumab (HUMIRA™, Abbott) in patients with rheumatoid arthritis:: A Swedish analysis. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S611 - S611
- [7] Workplace impacts of adalimumab (HUMIRA®) in patients with rheumatoid arthritis (RA) ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S459 - S459
- [10] Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (10): : 1006 - 1015